眼科新进展2018，Vol.38Issue(2)：188-192,5.DOI:10.13389/j.cnki.rao.2018.0043
葡萄膜黑色素瘤的药物治疗研究现状
Research advances in the treatment for uveal melanoma
摘要
Abstract
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults.Despite the availability of local treatment modalities,the survival rates of patients with UM have not improved in 30 years.And the main reason is lack of therapeutic drugs for UM,especially agents that inhibit tumor metastasis.Foreign researchers have carried out extensive clinical trials on the agents,but traditional ocular enucleation has been performed for the treatment of UM without any clinical drug tests in China.This paper will give a review on these clinical trials abroad,hoping to provide insight in the treatment of UM for domestic ophthalmologists and oncologist.关键词
葡萄膜黑色素瘤/药物治疗/临床试验Key words
uveal melanoma/medication/clinical trials分类
医药卫生引用本文复制引用
郑磊,温佳敏,张国明..葡萄膜黑色素瘤的药物治疗研究现状[J].眼科新进展,2018,38(2):188-192,5.基金项目
深圳市国际合作项目(编号:GJHZ20160229170623135)Shenzhen International Cooperation Project (No:GJHZ20160229170623135) （编号:GJHZ20160229170623135）
